Table 3.

Comparison of outcomes afterautologous HCTfor pPCL between 2000 and 2006 (vs. MM patients during the same time period).

Outcomes	PPCL N-68	MM N-1380	P-value
Non-relapse mortality
@ 1 year	1 (0-6)	4 (3-6)	0.06*
@ 3 years	4 (0-12)	7 (5-8)	0.443*
@ 5 years	4 (0-12)	8 (7-10)	0.178*
Relapse/Progression
@ 1 year	29 (18-42)	28 (25-30)	0.854*
@ 3 years	64 (48-79)	59 (57-62)	0.57*
@ 5 years	77 (60-91)	74 (71-77)	0.703*
Progression free survival
@ 1 year	70 (57-81)	68 (65-70)	0.783*
@ 3 years	32 (18-48)	34 (31-37)	0.777*
@ 5 years	19 (6-36)	17 (15-20)	0.891*
Overall survival
@ 1 year	86 (76-93)	89 (87-91)	0.439*
@ 3 years	68 (52-81)	67 (64-69)	0.913*
@ 5 years	51 (32-71)	49 (46-53)	0.848*

^*Pointwise